MaxCyte, Inc. Share Price & Technical Analysis
MXCT · $1.04 (-1.89%)
Healthcare / Medical Devices
$1.04
-1.89%
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-bas…
Price chart
Seasonality
May has 2 positive and 3 negative years (last 5 years shown)
11% return in May, -2% avg return in past 3 year May month.
-28% return in 2026, -19% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -44% | -11% | -12% | 29% | 11% | – | – | – | – | – | – | – | -28% |
| 25 | 13% | -25% | -21% | 4% | -14% | -4% | -5% | -30% | 14% | 0% | 20% | -12% | -60% |
| 24 | 9% | -10% | -9% | -14% | 25% | -13% | 23% | -10% | -7% | -8% | -5% | 17% | -4% |
| 23 | 5% | -22% | 9% | 2% | -18% | 12% | -2% | -20% | -16% | -3% | 60% | 0% | 7% |
| 22 | -37% | 8% | 0% | -24% | -15% | 2% | 15% | -4% | 25% | 6% | -14% | -8% | -46% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Downtrend · Uptrend
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$87.64M
P/E ratio
—
52W high
$2.40
52W low
$0.64
Volume
8,09,075
Beta
1.57
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is MaxCyte, Inc. share price today?
- MaxCyte, Inc. (MXCT) last traded around $1.04 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does MXCT have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for MXCT. Download the app for real-time alerts.
- How can I analyze MaxCyte, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.